|
PIBF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.106800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.654800E-01 |
| Normal-vs-Stage2 |
6.351600E-01 |
| Normal-vs-Stage3 |
9.625800E-01 |
| Normal-vs-Stage4 |
8.877400E-01 |
| Stage1-vs-Stage2 |
5.732000E-01 |
| Stage1-vs-Stage3 |
9.417800E-01 |
| Stage1-vs-Stage4 |
8.106400E-01 |
| Stage2-vs-Stage3 |
6.618400E-01 |
| Stage2-vs-Stage4 |
7.084200E-01 |
| Stage3-vs-Stage4 |
9.199400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.306600E-01 |
| Normal-vs-AfricanAmerican |
3.921200E-01 |
| Normal-vs-Asian |
8.697600E-02 |
| Caucasian-vs-AfricanAmerican |
3.849200E-01 |
| Caucasian-vs-Asian |
2.564600E-01 |
| AfricanAmerican-vs-Asian |
1.223790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.189800E-01 |
| Normal-vs-Female |
2.151800E-01 |
| Male-vs-Female |
1.240030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.286800E-01 |
| Normal-vs-Extreme_Weight |
8.929800E-01 |
| Normal-vs-Obese |
3.236200E-01 |
| Normal-vs-Extreme_Obese |
8.326200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.738800E-01 |
| Normal_Weight-vs-Obese |
3.276000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.030800E-01 |
| Extreme_Weight-vs-Obese |
2.736200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.269200E-01 |
| Obese-vs-Extreme_Obese |
4.968200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.593600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.198100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.079800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.346000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.506400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.810000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.753800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.723600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.885800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.766000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.701620E-01 |
| Normal-VS-Type2 PRCC |
4.126300E-02 |
| Normal-VS-KIRP CIMP |
6.414800E-01 |
| Normal-VS-Unclassified PRCC |
6.830600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.449610E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.907700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.955200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.392170E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.578200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.053600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.245200E-01 |
| Normal-vs-N1 |
3.179200E-01 |
| Normal-vs-N2 |
1.330570E-01 |
| N0-vs-N1 |
5.534300E-02 |
| N0-vs-N2 |
5.107200E-01 |
| N1-vs-N2 |
1.173760E-01 |
|
|
